12.18.24 Study shows link between semaglutide use and NAION A December study showed that a once-weekly semaglutide doubles the five-year risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
The key findings include the following: From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4 percent in 2019 to 15.7 percent in 2024, a relative increase of 50.7 percent
Si bien cada circunstancia debe ser individualizada para sugerir la suspensin de este tipo de medicamentos previo a un estudio endoscpico, se debe explicar los riesgos y beneficios al momento de firmar el consentimiento informado.
GLP-1 enrollment historically peaks at the start of the year, when employees activate new benefits and reset health goals, which means January and February are our highest-volume months
Optimizing your tirzepatide results while managing expiration concerns Expiration management should support your results, not distract from them
Because GLP-1 medications carry a risk of vitamin deficiencies, a proper GLP-1 diet plan should include nutritionist-designed meals rich in essential vitamins and nutrients